Pressure–volume (PV) analysis is the most comprehensive way to describe cardiac function,
giving insights into cardiac mechanics and energetics. However, PV analysis still remains a …

Background: Up to 30–50% of chronic heart failure patients who underwent cardiac
resynchronization therapy (CRT) do not respond to the treatment. Therefore, patient …

Finding reliable parameters to identify patients with heart failure (HF) that will respond to
cardiac resynchronization therapy (CRT) represents a major challenge. We and others have …

Aims Cardiac implantable electronic device (CIED) therapy is fundamental to the
management of LMNA cardiomyopathy due to the high frequency of atrioventricular block …

Non-responders to Cardiac Resynchronization Therapy (CRT) represent a high-risk, and
difficult to treat population of heart failure patients. Studies have shown that these patients …

Purpose Disturbed autonomic function is implicated in high mortality rates in heart failure
patients. High-intensity vagus nerve stimulation therapy was shown to improve intrinsic heart …

Background There are limited data about cardiac resynchronization therapy (CRT) in adult
congenital heart disease. We aimed to assess early and late outcomes of CRT among …

Objectives: This study hypothesized that guided implants, in which the optimal left ventricular
endocardial (LVENDO) pacing location was identified and targeted, would improve acute …

Background: Fusion CRT pacing (FCRT) is noninferior to biventricular pacing, according to
the current data. The aim of this study is to assess the response to FCRT and to identify …

Cardiac resynchronization therapy (CRT) is a good treatment for heart failure accompanied
by ventricular conduction abnormalities. Current ECG criteria in international guidelines …